European Archives - Page 153 of 1346 - European Medical Journal

Air Pollution Exposure Linked to Higher Dementia Risk

Long-term exposure to fine particulate matter and nitrogen dioxide is linked to increased dementia risk, according to a major new meta-analysis involving over 24 million people.

First Human PET Study Validates Intranasal Insulin Delivery to Brain

Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s treatments.

No Link Between Aluminium in Vaccines and Autism or ADHD, Landmark Study Finds

Study of over one million children finds no link between aluminium in vaccines and autism or chronic illnesses.

Iron Deficiency Without Anaemia Linked to Brain Changes in Teenagers

A new study has found that iron deficiency (ID) without anaemia may impact brain development in adolescents….

Thyroid Hormones Linked to Gestational Diabetes Risk

Low thyroid hormone levels may increase gestational diabetes risk, with isolated hypothyroxinaemia showing the strongest association.

Immunotherapy Combo Shows Promise in Lung Cancer

The BTCRC LUN 16-081 trial is the first to evaluate a shorter, six-month course of consolidation immunotherapy using nivolumab alone or in combination with ipilimumab.

Ketamine Reduces Inflammation After Liver Resection

The study explored the anti-inflammatory and analgesic effects of low-dose ketamine and Dex, both commonly used anaesthetic agents with known immune-modulating properties.

Ear-Clip Device Boosts Fitness in Adults via Vagus Nerve Stimulation

Vagus nerve stimulation significantly boosts fitness and reduces inflammation, UK trial finds. Discover if it could benefit you.

New Drug Pairing Offers Hope for Advanced Skin Lymphoma

A new combination treatment may offer a promising option for patients with relapsed or refractory cutaneous T-cell lymphoma….

Home-Based Brain Stimulation Reduces Pain and Disability in Fibromyalgia

A randomised trial finds that home-based brain stimulation plus exercise and education reduces pain-related disability in fibromyalgia patients, even among placebo responders.